Comprehensive search ChatGPT Online Scientific research tools
Sign in Sign Up

Science hub Mutual Aid community


[Other] Safety and Efficacy of CD19 CAR-T Cells Co-Expressing IL-7 and CCL19 in Combination with Anti-PD-1 Antibody for Refractory/Relapsed DLBCL: Preliminary Data from the Phase Ⅰb Trial (NCT04381741)

gladstonreis Post time 3 day(s) ago | Show all posts |Read mode
Reward20points

journal：Blood

Authors：Wenbin Qian; Aiqi Zhao; Hui Liu; Wen Lei; Yun Liang; Xianggui Yuan

Published date：2021-11-5

DOI：10.1182/blood-2021-144523

PDF link：https://ashpublications.org/bloo ... CD19-CAR-T-Cells-Co

Article link：http://dx.doi.org/10.1182/blood-2021-144523

Article Source：American Society of Hematology。


Remark：
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
Akoni01S22 Post time 3 day(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

gladstonreis Lv.2
Junior Member

  • post

  • reply

  • points

    30

Same Category

Latest Reply

Announcement

Enthusiastic users today

Return to the list